Loading chat...
FL S0700
Bill
AI Summary
- Amends Florida Statute 893.03 to exempt xylazine animal drug products approved by the U.S. Food and Drug Administration from classification as a Schedule I controlled substance, provided the use conforms to the approved application or is authorized under federal law (21 U.S.C. s. 360b(a)(4))
- Explicitly prohibits the exception from applying to the manufacture, importation, distribution, prescribing, or sale of xylazine for human use, which remains a Schedule I violation
- Xylazine remains listed as a Schedule I hallucinogenic substance under Florida law for all purposes not covered by the FDA-approved veterinary exception
- Sponsored by Senator Gruters for the 2024 Florida legislative session with a proposed effective date of July 1, 2024
Legislative Description
Controlled Substances
Last Action
Died in Judiciary
3/8/2024
Committee Referrals
Judiciary1/16/2024
Full Bill Text
No bill text available